Latest Breaking News On - Zevra therapeutics inc - Page 6 : comparemela.com

ZEVRA ALERT: Bragar Eagel & Squire, P C is Investigating

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating.

New yorkUnited statesSouth carolinaBragar eagel squireBrandon walkerMarion passmoreCompany annual report on formCompany quarterly reports on formZevra therapeutics incAudit committeeExchange commissionZevra therapeuticsCurrent reportUnited states securitiesAnnual reportQuarterly reports

ZEVRA ALERT: Bragar Eagel & Squire, P C is Investigating Zevra Therapeutics, Inc on Behalf of Zevra Stockholders and Encourages Investors to Contact the Firm

ZEVRA ALERT: Bragar Eagel & Squire, P C is Investigating Zevra Therapeutics, Inc on Behalf of Zevra Stockholders and Encourages Investors to Contact the Firm
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth carolinaNew yorkBragar eagel squireBrandon walkerMarion passmoreCompany quarterly reports on formAudit committeeZevra therapeutics incExchange commissionCompany annual report on formZevra therapeuticsCurrent reportUnited states securitiesAnnual reportQuarterly reports

Q1 2025 Earnings Forecast for Zevra Therapeutics, Inc (NASDAQ:ZVRA) Issued By William Blair

Q1 2025 Earnings Forecast for Zevra Therapeutics, Inc (NASDAQ:ZVRA) Issued By William Blair
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairCantor fitzgeraldZevra therapeutics incInternational assets investment managementVisionpoint advisory groupMaxim groupZevra therapeutics company profileZevra therapeuticsFree reportZevra therapeuticTherapeutics stock downPoint advisory groupEmployees retirement systemState teachers retirement systemAssets investment management

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc - ZVRA

NEW YORK, April 4, 2024 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc. . Such investors are advised to contact Danielle Peyton at.

New yorkUnited statesTel avivCity ofUnited kingdomFrance generalAbrahaml pomerantzDanielle peytonLos angelesAudit committeePrnewswire pomerantzCompany quarterly reports on formZevra therapeutics incExchange commissionCompany annual report on formZevra therapeutics

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc

/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc. ("Zevra" or the "Company") (NASDAQ: ZVRA). Such.

Tel avivCity ofUnited kingdomNew yorkUnited statesFrance generalLos angelesDanielle peytonAbrahaml pomerantzCompany annual report on formExchange commissionZevra therapeutics incCompany quarterly reports on formAudit committeePrnewswire pomerantzZevra therapeutics